News from gsk A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

Aug 08, 2018, 14:18 ETGSK ships 2018-19 seasonal influenza vaccines for US market

GSK today announced it will begin shipping its quadrivalent influenza vaccines to US healthcare providers and pharmacies for the 2018-19 flu season,...


Feb 21, 2018, 10:30 ETGSK presents new efficacy data for FLUARIX® QUADRIVALENT (Influenza Vaccine) in children 6 months through 35 months of age

GSK presented today at the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices meeting that FLUARIX®...


Jan 12, 2018, 08:00 ETGSK receives FDA approval for expanded indication for FLUARIX® QUADRIVALENT (Influenza Vaccine) for persons 6 months and older

GSK [LSE/NYSE: GSK] announced today it has received approval from the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and...


Nov 14, 2017, 09:00 ETNew survey shines light on critical gaps in adult vaccination knowledge

Even though vaccines are one of the greatest health innovations of the last century, a new survey shows that among some adults in America there is a...


Nov 07, 2017, 11:00 ETGSK Presents New Data at ACR for BENLYSTA (belimumab) for Subcutaneous Use (SC), Showing Reduced Need to Increase Corticosteroid Dose

GSK today announced results from BLISS-SC, a 52-week study for BENLYSTA (belimumab) for subcutaneous use (SC) in adult patients with active,...


Nov 06, 2017, 10:00 ETNew GSK Multi-country Survey Reveals Need for Improved Awareness Around Long-term Impact and Appropriate use of Corticosteroids in SLE Management

Findings from a new multi-country GSK survey, released today to coincide with the 2017 American College of Rheumatology/Association for Rheumatology...


Oct 25, 2017, 13:52 ETCDC's Advisory Committee on Immunization Practices recommends Shingrix as the preferred vaccine for the prevention of shingles for adults aged 50 and up

GlaxoSmithKline plc [LSE/NYSE: GSK] today announced that the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization ...


Oct 20, 2017, 19:16 ETShingrix approved in the US for prevention of shingles in adults aged 50 and over

GlaxoSmithKline plc [LSE/NYSE: GSK] today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, ...


Sep 13, 2017, 15:49 ETFDA Advisory Committee votes unanimously for Shingrix (HZ/su) in the US for prevention of herpes zoster (shingles) in adults ages 50 and over

GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the US Food and...


Jul 21, 2017, 15:18 ETGSK receives FDA approval for a new self-injectable formulation of Benlysta (belimumab) for systemic lupus erythematosus

GSK announced today that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Benlysta (belimumab) for the...


Jul 14, 2017, 16:56 ETGSK ships 2017-18 seasonal influenza vaccines for US market

GSK (LSE/NYSE: GSK) today announced it has begun shipping quadrivalent vaccine doses to US healthcare providers, following licensing and lot-release...


Jun 21, 2017, 11:19 ETGSK presents positive results from Phase III revaccination study of its candidate shingles vaccine Shingrix at CDC's Advisory Meeting

GSK (LSE/NYSE: GSK) today will be presenting new results from a clinical study showing that its candidate vaccine for the prevention of herpes zoster ...


May 01, 2017, 10:05 ETGSK invests $139 million to expand production capacity for BENLYSTA (belimumab) in Rockville, MD

GSK today announced $139 million of new investment in its biopharmaceutical manufacturing site in Rockville, MD to support growing demand for...


Mar 15, 2017, 11:13 ETGSK announces US regulatory submission seeking expanded indication for Fluarix® Quadrivalent (Influenza Vaccine) for infants 6 months and older

GSK [LSE/NYSE: GSK] today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration...


Mar 06, 2017, 09:20 ETGSK's MUSCA study shows Nucala® (mepolizumab) significantly improves quality of life and lung function in severe asthma patients with an eosinophilic phenotype

GlaxoSmithKline plc (LSE/NYSE:GSK) today announced data demonstrating that severe asthma patients, whose disease is driven by eosinophilic...


Jan 19, 2017, 08:30 ETGSK Announces Winners of 2016 Discovery Fast Track Boston Challenge

GSK has named two academic researchers winners of the 2016 Discovery Fast Track Boston Challenge. The Challenge is sponsored by GSK's Discovery...


Nov 21, 2016, 08:28 ETGSK receives FDA approval for expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 months and older

GSK [LSE/NYSE: GSK] announced today it has received approval from the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and...


Nov 16, 2016, 11:14 ETGSK's Benlysta® (belimumab) Shows Sustained Benefits in Patients with SLE

Results from 7-year Phase III continuation study in US patients GSK today announced results from a 7-year safety and efficacy continuation study for...


Nov 14, 2016, 10:28 ETGSK Announces Positive Results in Fourth Consecutive Pivotal Trial of Benlysta® (belimumab) in SLE

Data in Japan, China and South Korea will form basis of new regulatory submissions for Benlysta GSK today announced positive efficacy and safety data ...


Oct 27, 2016, 09:11 ETGSK presents new data for shingles candidate vaccine at IDWeek scientific conference

GSK today announced new data for its shingles candidate vaccine Shingrix™, at the Infectious Disease Week (IDWeek) scientific conference in New...


Sep 14, 2016, 05:38 ETGSK's candidate shingles vaccine shows high efficacy against shingles and its complications in adults aged 70 years and over in phase III study published in NEJM

GSK (LSE/NYSE: GSK) today announced the publication of detailed results from a randomised phase III study (ZOE-70) of its investigational shingles...


Aug 05, 2016, 11:00 ETGSK unveils campaign to help prevent meningitis

GSK (LSE: GSK) today launched an educational campaign to help raise awareness of meningitis, a rare but potentially deadly disease. Most teens and...


Jul 20, 2016, 03:51 ETGSK ships 2016-17 seasonal influenza vaccines for US market

GSK [LSE/NYSE: GSK] announced today it has begun shipping quadrivalent vaccine doses to US healthcare providers, following licensing and lot-release...


May 03, 2016, 08:00 ETNational survey of uncontrolled asthma patients finds majority mistakenly believe their asthma is under control

GSK today released data from a new national survey of more than 1,000 uncontrolled asthma patients showing that 67% of adults with uncontrolled...


Apr 22, 2016, 12:01 ETInternational Survey Released for World Meningitis Day Shows Parents Feel They Don't Know Enough About the Disease and its Consequences

An international survey conducted by GSK and released for World Meningitis Day shows gaps in the knowledge parents feel they have about meningococcal ...